EFFECTS OF ANGIOTENSIN II RECEPTOR BLOCKADE IN SYSTEMIC SCLEROSIS: RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Abou-Raya, A. [1 ,2 ]
Abou-Raya, S. [1 ,2 ]
Helmii, M. [3 ]
机构：
[1] Univ Alexandria, Fac Med, Alexandria, Egypt
[2] Alexandria Ctr Womens Hlth, Alexandria, Egypt
[3] Med Res Inst, Alexandria, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles - A multicenter, randomized, placebo-controlled clinical trial
    Dore, A
    Houde, C
    Chan, KL
    Ducharme, A
    Khairy, P
    Juneau, M
    Marcotte, F
    Mercier, LA
    CIRCULATION, 2005, 112 (16) : 2411 - 2416
  • [2] Antithrombotic effects of angiotensin II receptor blockade
    Vorchheimer, DA
    Zafar, MU
    Pandey, A
    Guzman, IC
    Rodriguez, J
    Reddy, B
    Cohen, MA
    Badimon, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 444A - 444A
  • [3] The Effects of the Angiotensin II Receptor Antagonist Losartan on Appetitive Versus Aversive Learning: A Randomized Controlled Trial
    Pulcu, Erdem
    Shkreli, Lorika
    Hoist, Carolina Guzman
    Woud, Marcella L.
    Craske, Michelle G.
    Browning, Michael
    Reinecke, Andrea
    BIOLOGICAL PSYCHIATRY, 2019, 86 (05) : 397 - 404
  • [4] Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial
    Tronvik, E
    Stovner, LJ
    Helde, G
    Sand, T
    Bovim, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (01): : 65 - 69
  • [5] Amelioration of Systemic Fibrosis in Mice by Angiotensin II Receptor Blockade
    Marut, Wioleta
    Kavian, Niloufar
    Servettaz, Amelie
    Thong Hua-Huy
    Nicco, Carole
    Chereau, Christiane
    Weill, Bernard
    Anh Tuan Dinh-Xuan
    Batteux, Frederic
    ARTHRITIS AND RHEUMATISM, 2013, 65 (05): : 1367 - 1377
  • [6] ANGIOTENSIN RECEPTOR BLOCKADE TREATMENT FOR COPD: PHASE II TRIAL
    Lambert, Allison
    Neptune, Enid
    Brown, Robert
    Diette, Gregory B.
    Drummond, M. Bradley
    Hansel, Nadia N.
    Liu, Mark
    Shade, David
    Wise, Robert
    RESPIROLOGY, 2016, 21 : 16 - 16
  • [7] Angiotensin Receptor Blockade Treatment for COPD: Phase II Trial
    Lambert, Allison
    Neptune, Enid
    Brown, Robert
    Diette, Gregory
    Drummond, M.
    Hansel, Nadia
    Liu, Mark
    Shade, David
    Wise, Robert
    CHEST, 2015, 148 (04)
  • [8] Neural and hypotensive effects of angiotensin II receptor blockade
    Rongen, GA
    Brooks, SC
    Ando, S
    Dajani, HR
    Abramson, BL
    Floras, JS
    HYPERTENSION, 1998, 31 (01) : 378 - 383
  • [9] Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial
    Iseki, Kunitoshi
    Arima, Hisatomi
    Kohagura, Kentaro
    Komiya, Ichiro
    Ueda, Shinichiro
    Tokuyama, Kiyoyuki
    Shiohira, Yoshiki
    Uehara, Hajime
    Toma, Shigeki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) : 1579 - 1589
  • [10] EFFECTS OF AN ANGIOTENSIN II RECEPTOR BLOCKADE ON BRAIN RENIN-ANGIOTENSIN SYSTEM
    Pelisch, Nicolas
    Hosomi, Naohisa
    Nishiyama, Akira
    Kohno, Masakazu
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 467 - 467
12345